Insider · CIK 0001780664
Julie Rubinstein
coopresidentofficer
Files at ADPT (Adaptive Biotechnologies Corp). First filing Mar 6, 2025, latest Oct 8, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $2.4M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADPT: Adaptive Biotechnologies Corp
ADPTOct 9, 2026 · close 26.49
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | Adaptive Biotechnologies Corp | $948k 35,643 shares | -9% | +117% from low-10% from high | |
| 25Weak | Adaptive Biotechnologies Corp | $1.0M 35,643 shares | -9% | +121% from low-7% from high | |
| 51Moderate | Adaptive Biotechnologies Corp | $416k 59,505 shares | -9% | +101% from low-6% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 4 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -9,381 | $27.36 | $257k | 380,302 | 4 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -1,100 | $28.21 | $31k | 379,202 | 4 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -901 | $29.71 | $27k | 378,301 | 4 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -499 | $30.53 | $15k | 377,802 | 4 d ago |
| Oct 7, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 4 d ago |
| Oct 7, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -11,881 | $26.40 | $314k | 377,802 | 4 d ago |
| Oct 8, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 4 d ago |
| Oct 8, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -11,881 | $25.66 | $305k | 377,802 | 4 d ago |
| Oct 6, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 332,253 | 4 d ago |
| Oct 7, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 320,372 | 4 d ago |
| Oct 8, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 308,491 | 4 d ago |
| Oct 1, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 7 d ago |
| Oct 1, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -6,081 | $27.57 | $168k | 383,602 | 7 d ago |
| Oct 1, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -5,800 | $28.56 | $166k | 377,802 | 7 d ago |
| Oct 2, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 7 d ago |
| Oct 2, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -11,881 | $28.13 | $334k | 377,802 | 7 d ago |
| Oct 5, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +11,881 | $12.14 | $144k | 389,683 | 7 d ago |
| Oct 5, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -6,699 | $28.82 | $193k | 382,984 | 7 d ago |
| Oct 5, 2026 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -5,182 | $29.67 | $154k | 377,802 | 7 d ago |
| Oct 1, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 367,896 | 7 d ago |
| Oct 2, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 356,015 | 7 d ago |
| Oct 5, 2026 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,881 | $0.00 | $0 | 344,134 | 7 d ago |
| Mar 4, 2025 | ADPT Adaptive Biotechnologies Corp | AGrant or award Common Stock | +175,000 | $0.00 | $0 | 647,754 | Mar 6, 2025 |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock | -40,044 | $6.98 | $280k | 607,710 | Mar 6, 2025 |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock | -19,461 | $6.99 | $136k | 588,249 | Mar 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.